President Donald Trump during his second State of the Union address on Tuesday, Feb. 5, pleaded with Congress to pass legislation targeting drug pricing practices of pharmaceutical companies.
Some of his calls to lower prescription drug prices received bipartisan support, STAT reports.
“It is unacceptable that Americans pay vastly more than people in other countries for the exact same drugs, often made in the exact same place,” Trump said. “This is wrong, unfair, and together we can stop it.”
Trump during his address, however, claimed that his administration was responsible for reducing drug prices in 2018.
“Already, as a result of my administration’s efforts, in 2018 drug prices experienced their single largest decline in 46 years,” he said.
According to STAT’s report, Trump was citing the consumer price index, not actual list prices.
To read the full report on STAT, click here.
